#pharmaceuticals

#pharmaceuticals

Novartis increased its mid-term sales growth forecast to 6%, expecting significant advances through pipeline assets and peak sales of key medications.

Takeda eliminated 'IT' to emphasize technology as a core business function and restructured for internal innovation and alignment with business goals.

GSK reported a £58 million loss due to Zantac settlement, contrasting with a £1.5 billion profit last year.

Struggles with acne often intertwine with societal beauty standards, impacting mental health and self-esteem.

The author highlights the emotional and psychological challenges of dealing with severe acne and beauty culture.

Sun Pharma's en banc petition contests a controversial Federal Circuit decision regarding obviousness-type double patenting and written description support.

The Allergan decision may set problematic precedents for patent families and disclosure requirements.

Bright Green aims to grow cannabis and opium poppies for pharmaceutical production, focusing on scientific research rather than retail marijuana.

Asking pointed questions during an interview can reveal critical insights about a company's product and strategy.

Healthy lifestyle can prolong life but can't prevent aging; advanced biotechnology may offer new solutions for longevity.

The field of longevity biotechnology is developing, aimed at combatting aging more effectively than traditional health measures.

AstraZeneca employees are under investigation for potential data privacy breaches and the import of unauthorized cancer medications in China.

ServiceNow assures investors that while returns from GenAI are not immediate, significant long-term benefits may reshape industries.

Generative AI's potential in pharma includes reducing product development timelines, leading to substantial cost savings.

A novel marketplace for compounded medications has emerged due to high demand and limited supply, directly impacting access to weight-loss drugs.

Prozac contamination in waterways disrupts fish behaviour and health, threatening their survival.

Denmark's economy is significantly influenced by its pharmaceutical industry, highlighting both growth potential and volatility.

The obscurity of a federal statute is enabling US pharmacies to flood the market with unvetted knockoffs of popular weight-loss drug Ozempic.

Online pharmaceutical brands Hims & Hers are introducing a cost-effective weight-loss drug with semaglutide.

Employers may stop counting copay assistance from drugmakers towards annual deductibles, leading patients to pay more out-of-pocket.

Patients can face unexpected high bills for medications when insurers or employers implement copay accumulator programs.

A human pill is being developed for Lyme disease prevention which can kill ticks within 24 hours and provide protection for up to 30 days.

Merck & Co. is acquiring Harpoon Therapeutics for $680 million in cash.

The acquisition price of $23 per share is more than double Harpoon's closing price of $10.55.

The UK has authorized a gene-editing medicine for treating sickle cell disease and beta thalassemia, marking the first approval worldwide for a therapy based on CRISPR technology.

The therapy, known as Casgevy, involves editing a gene in a patient's stem cells to produce high levels of fetal hemoglobin.

Casgevy offers a potentially curative treatment option for these inherited blood disorders, reducing the need for chronic therapies and blood transfusions.

Pfizer and Moderna's stock prices surged during the Covid panic

Pfizer became the first pharmaceutical company to have over $100 billion in annual sales in 2022

The FDA crackdown on products for premature babies has left doctors without a key tool for preventing a deadly gut disease.

Probiotics have been used for years to protect prematurely born babies, but American hospitals have stopped using them due to recent FDA restrictions.

37% of employees trust their insurer to suggest high-quality care regardless of cost, while 53% trust their employer with their health.

Employees need more support from their employers when it comes to healthcare, as many have had to delay or skip care due to lack of paid time off.

Weight management is a major concern for employees, with obesity/weight loss being the biggest personal health worry for a quarter of respondents.